EVKIF
Undervalued by 84.1% based on the discounted cash flow analysis.
Market cap | $10.29 Billion |
---|---|
Enterprise Value | $13.86 Billion |
Dividend Yield | $1.21 (5.93306288032454%) |
Earnings per Share | $0.48 |
Beta | 1.02 |
Outstanding Shares | 466,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 41.39 |
---|---|
PEG | -12.46 |
Price to Sales | 0.69 |
Price to Book Ratio | 1.16 |
Enterprise Value to Revenue | 0.91 |
Enterprise Value to EBIT | 12.86 |
Enterprise Value to Net Income | 60 |
Total Debt to Enterprise | 0.29 |
Debt to Equity | 0.45 |
No data
No data
Evonik Industries AG is a holding company, which engages in the manufacture of specialty chemical products. It operates through the following segments: Nutrition and Care, Resource Efficiency, Performance Materials, Services, and Other O...